nousivan
Nousivan is a synthetic cannabinoid receptor agonist, also known as a designer drug, that was first identified in 2013. It is a member of the indazole class of compounds, which are synthetic analogs of the natural cannabinoid anandamide. Nousivan is known for its potent psychoactive effects, including euphoria, increased energy, and altered perception of time. It is typically ingested in the form of pills, powders, or liquids, and its effects can last for several hours.
The pharmacology of nousivan involves the activation of cannabinoid receptors in the brain, particularly CB1 and
Nousivan has gained attention due to its potential for abuse and the associated risks. Like other synthetic
The detection of nousivan in drug testing is challenging due to its structural similarity to other cannabinoids.